Nassim Usman - 09 Feb 2022 Form 4 Insider Report for CATALYST BIOSCIENCES, INC. (GYRE)

Role
President & CEO, Director
Signature
/s/ Seline Miller, Attorney-in-Fact for Nassim Usman
Issuer symbol
GYRE
Transactions as of
09 Feb 2022
Net transactions value
+$1,495
Form type
4
Filing time
16 Feb 2022, 19:13:34 UTC
Previous filing
11 Aug 2021
Next filing
10 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CBIO Common Stock Purchase $1,495 +3,250 +18% $0.4600 21,291 09 Feb 2022 Direct F1
holding CBIO Common Stock 8,456 09 Feb 2022 By The Usman Family Trust
holding CBIO Common Stock 1,168 09 Feb 2022 By Nassim Usman IRA
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased under the Issuer's 2018 Employee Stock Purchase Plan on February 9, 2022.